MLH1 and cancer: Although not all BRAF mutated colorectal cancers are MSI high, the association of BRAF mutations with MSI and CIMP has been previously reported and MSI is commonly the result of MLH1 suppression through promoter methylation in cancers with BRAF mutations [28].